HK1201449A1 - Treating neuropathic pain with seh inhibitors seh - Google Patents
Treating neuropathic pain with seh inhibitors sehInfo
- Publication number
- HK1201449A1 HK1201449A1 HK15101946.6A HK15101946A HK1201449A1 HK 1201449 A1 HK1201449 A1 HK 1201449A1 HK 15101946 A HK15101946 A HK 15101946A HK 1201449 A1 HK1201449 A1 HK 1201449A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- seh
- neuropathic pain
- inhibitors
- treating neuropathic
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261593811P | 2012-02-01 | 2012-02-01 | |
PCT/US2013/024429 WO2013116713A1 (fr) | 2012-02-01 | 2013-02-01 | Traitement de la douleur neuropathique avec des inhibiteurs de seh |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201449A1 true HK1201449A1 (en) | 2015-09-04 |
Family
ID=48905897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15101946.6A HK1201449A1 (en) | 2012-02-01 | 2015-02-26 | Treating neuropathic pain with seh inhibitors seh |
Country Status (5)
Country | Link |
---|---|
US (1) | US9850207B2 (fr) |
EP (1) | EP2809314A4 (fr) |
CN (1) | CN104136022A (fr) |
HK (1) | HK1201449A1 (fr) |
WO (1) | WO2013116713A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013116690A1 (fr) * | 2012-02-01 | 2013-08-08 | The Regents Of The University Of California | Inhibiteurs à base d'acyl pipéridine de l'hydrolase époxyde soluble |
PL3129023T3 (pl) | 2014-03-27 | 2021-08-16 | Eicosis, Llc | Silne inhibitory rozpuszczalnej hydrolazy epoksydowej |
US10813894B2 (en) | 2015-02-20 | 2020-10-27 | The Regents Of The University Of California | Methods of inhibiting pain |
CN108658897B (zh) * | 2017-03-30 | 2022-02-15 | 上海医药工业研究院 | 乙酰苄胺哌嗪和/或哌啶类衍生物及其作为脑神经保护剂的应用 |
US20210161881A1 (en) * | 2018-02-06 | 2021-06-03 | The Regents Of The University Of California | Methods of inhibiting formation of alpha synuclein aggregates |
WO2019221528A1 (fr) * | 2018-05-17 | 2019-11-21 | Helixmith Co., Ltd. | Traitement de la douleur neuropathique associée à une neuropathie périphérique induite par une chimiothérapie |
CN111574432A (zh) * | 2020-06-17 | 2020-08-25 | 安徽省逸欣铭医药科技有限公司 | 一种可溶性环氧水解酶和γ-氨基丁酸双重抑制剂及用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR058277A1 (es) * | 2005-12-09 | 2008-01-30 | Solvay Pharm Gmbh | N- sulfamoil - piperidin - amidas, composiciones farmaceuticas que las comprenden y procedimiento para su preparacion |
CN101535259A (zh) * | 2006-10-20 | 2009-09-16 | 亚瑞特医疗公司 | 作为可溶性环氧化物水解酶抑制剂的苯基脲化合物 |
TW200825072A (en) * | 2006-10-20 | 2008-06-16 | Arete Therapeutics Inc | Soluble epoxide hydrolase inhibitors |
EP2219450A4 (fr) * | 2007-11-08 | 2012-01-25 | Univ California | Soulagement de la douleur neuropathique au moyen d'eet et d'inhibiteurs de la seh |
US20090247521A1 (en) * | 2007-12-28 | 2009-10-01 | Arete Therapeutics, Inc. | Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
-
2013
- 2013-02-01 US US14/375,704 patent/US9850207B2/en active Active
- 2013-02-01 WO PCT/US2013/024429 patent/WO2013116713A1/fr active Application Filing
- 2013-02-01 EP EP13743566.5A patent/EP2809314A4/fr not_active Withdrawn
- 2013-02-01 CN CN201380010112.9A patent/CN104136022A/zh active Pending
-
2015
- 2015-02-26 HK HK15101946.6A patent/HK1201449A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN104136022A (zh) | 2014-11-05 |
US9850207B2 (en) | 2017-12-26 |
WO2013116713A1 (fr) | 2013-08-08 |
WO2013116713A9 (fr) | 2013-10-03 |
EP2809314A1 (fr) | 2014-12-10 |
US20150065540A1 (en) | 2015-03-05 |
EP2809314A4 (fr) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2819703A4 (fr) | Traitement de la douleur | |
EP2862620A4 (fr) | Système de traitement de gaz de décharge | |
GB201308058D0 (en) | Injector apparatus | |
HK1201449A1 (en) | Treating neuropathic pain with seh inhibitors seh | |
SG11201504957RA (en) | Water treatment method | |
EP2852559A4 (fr) | Procédé de traitement des boues | |
EP2777576A4 (fr) | Système de traitement | |
EP2789306A4 (fr) | Système de traitement | |
EP2803328A4 (fr) | Système de traitement | |
EP2930152A4 (fr) | Appareil de traitement de l'eau | |
GB201110781D0 (en) | Liquid treatment systems | |
EP2858634A4 (fr) | Composés pour le traitement de l'inflammation et de la douleur | |
HK1209040A1 (en) | Methods for treating vestibulotoxicity | |
ZA201308117B (en) | Avian-based treatment | |
EP2907890A4 (fr) | Procédé et dispositif de dépôt physique en phase vapeur | |
GB2493633B (en) | Barrel treatment apparatus | |
EP2861228A4 (fr) | Composés destinés au traitement de l'inflammation et de la douleur | |
GB201209198D0 (en) | Liquid treatment | |
GB201209283D0 (en) | Liquid treatment | |
GB201211135D0 (en) | Treatment | |
GB201208690D0 (en) | Treatment | |
EP2838532A4 (fr) | Procédé de traitement de la sclérodermie | |
HUP1200221A2 (en) | Sludge treatment | |
PT2684697T (pt) | Instalação de tratamento | |
GB201205449D0 (en) | Treatment process |